374 related articles for article (PubMed ID: 36686803)
1. When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective.
Zhang Z; Bao C; Jiang L; Wang S; Wang K; Lu C; Fang H
Front Oncol; 2022; 12():1054233. PubMed ID: 36686803
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Metabolomics in Hematopoiesis and Hematological Malignancies.
Zuo F; Yu J; He X
Front Oncol; 2022; 12():931393. PubMed ID: 35912231
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming in cervical cancer and metabolomics perspectives.
Li B; Sui L
Nutr Metab (Lond); 2021 Oct; 18(1):93. PubMed ID: 34666780
[TBL] [Abstract][Full Text] [Related]
4. Spatial metabolomics in head and neck tumors: a review.
Zheng Y; Lin C; Chu Y; Gu S; Deng H; Shen Z
Front Oncol; 2023; 13():1213273. PubMed ID: 37519782
[TBL] [Abstract][Full Text] [Related]
5. To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.
Danzi F; Pacchiana R; Mafficini A; Scupoli MT; Scarpa A; Donadelli M; Fiore A
Signal Transduct Target Ther; 2023 Mar; 8(1):137. PubMed ID: 36949046
[TBL] [Abstract][Full Text] [Related]
6. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming.
Han J; Li Q; Chen Y; Yang Y
Front Mol Biosci; 2021; 8():763902. PubMed ID: 34901157
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics, metabolic flux analysis and cancer pharmacology.
Liang L; Sun F; Wang H; Hu Z
Pharmacol Ther; 2021 Aug; 224():107827. PubMed ID: 33662451
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics at the tumor microenvironment interface: Decoding cellular conversations.
Berrell N; Sadeghirad H; Blick T; Bidgood C; Leggatt GR; O'Byrne K; Kulasinghe A
Med Res Rev; 2024 May; 44(3):1121-1146. PubMed ID: 38146814
[TBL] [Abstract][Full Text] [Related]
9. The prowess of metabolomics in cancer research: current trends, challenges and future perspectives.
Taunk K; Jajula S; Bhavsar PP; Choudhari M; Bhanuse S; Tamhankar A; Naiya T; Kalita B; Rapole S
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38814423
[TBL] [Abstract][Full Text] [Related]
10. Spatially resolved metabolomics to discover tumor-associated metabolic alterations.
Sun C; Li T; Song X; Huang L; Zang Q; Xu J; Bi N; Jiao G; Hao Y; Chen Y; Zhang R; Luo Z; Li X; Wang L; Wang Z; Song Y; He J; Abliz Z
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):52-57. PubMed ID: 30559182
[TBL] [Abstract][Full Text] [Related]
11. The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties.
Wei D; Xu M; Wang Z; Tong J
Front Oncol; 2021; 11():814085. PubMed ID: 35083160
[TBL] [Abstract][Full Text] [Related]
12. Capillary microsampling-based single-cell metabolomics by mass spectrometry and its applications in medicine and drug discovery.
Abouleila Y; Ali A; Masuda K; Mashaghi A; Shimizu Y
Cancer Biomark; 2022; 33(4):437-447. PubMed ID: 35491767
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics in cancer research and emerging applications in clinical oncology.
Schmidt DR; Patel R; Kirsch DG; Lewis CA; Vander Heiden MG; Locasale JW
CA Cancer J Clin; 2021 Jul; 71(4):333-358. PubMed ID: 33982817
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics in oncology.
Suri GS; Kaur G; Carbone GM; Shinde D
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1795. PubMed ID: 36811317
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
[TBL] [Abstract][Full Text] [Related]
16. Application of metabolomics technologies toward cancer prognosis and therapy.
Hoang G; Udupa S; Le A
Int Rev Cell Mol Biol; 2019; 347():191-223. PubMed ID: 31451214
[TBL] [Abstract][Full Text] [Related]
17. Application of metabolomics in drug resistant breast cancer research.
Shajahan-Haq AN; Cheema MS; Clarke R
Metabolites; 2015 Feb; 5(1):100-18. PubMed ID: 25693144
[TBL] [Abstract][Full Text] [Related]
18. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
Xie J; Zhang AH; Qiu S; Zhang TL; Li XN; Yan GL; Sun H; Liu L; Wang XJ
J Proteomics; 2019 Aug; 206():103447. PubMed ID: 31326558
[TBL] [Abstract][Full Text] [Related]
19. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer.
Sun C; Wang A; Zhou Y; Chen P; Wang X; Huang J; Gao J; Wang X; Shu L; Lu J; Dai W; Bu Z; Ji J; He J
Nat Commun; 2023 May; 14(1):2692. PubMed ID: 37164975
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
